These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Increased intimal hyperplasia and smooth muscle cell proliferation in transgenic mice with heparan sulfate-deficient perlecan. Tran PK; Tran-Lundmark K; Soininen R; Tryggvason K; Thyberg J; Hedin U Circ Res; 2004 Mar; 94(4):550-8. PubMed ID: 14739157 [TBL] [Abstract][Full Text] [Related]
4. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation. Augé N; Maupas-Schwalm F; Elbaz M; Thiers JC; Waysbort A; Itohara S; Krell HW; Salvayre R; Nègre-Salvayre A Circulation; 2004 Aug; 110(5):571-8. PubMed ID: 15277330 [TBL] [Abstract][Full Text] [Related]
5. Early activation of internal medial smooth muscle cells in the rabbit aorta after mechanical injury: relationship with intimal thickening and pharmacological applications. Louis H; Lacolley P; Kakou A; Cattan V; Daret D; Safar M; Bonnet J; Daniel Lamazière JM Clin Exp Pharmacol Physiol; 2006; 33(1-2):131-8. PubMed ID: 16445712 [TBL] [Abstract][Full Text] [Related]
6. CREG promotes a mature smooth muscle cell phenotype and reduces neointimal formation in balloon-injured rat carotid artery. Han Y; Deng J; Guo L; Yan C; Liang M; Kang J; Liu H; Graham AM; Li S Cardiovasc Res; 2008 Jun; 78(3):597-604. PubMed ID: 18267954 [TBL] [Abstract][Full Text] [Related]
7. Targeted disruption of TGF-beta-Smad3 signaling leads to enhanced neointimal hyperplasia with diminished matrix deposition in response to vascular injury. Kobayashi K; Yokote K; Fujimoto M; Yamashita K; Sakamoto A; Kitahara M; Kawamura H; Maezawa Y; Asaumi S; Tokuhisa T; Mori S; Saito Y Circ Res; 2005 Apr; 96(8):904-12. PubMed ID: 15790953 [TBL] [Abstract][Full Text] [Related]
10. Deficiency of gelatinase a suppresses smooth muscle cell invasion and development of experimental intimal hyperplasia. Kuzuya M; Kanda S; Sasaki T; Tamaya-Mori N; Cheng XW; Itoh T; Itohara S; Iguchi A Circulation; 2003 Sep; 108(11):1375-81. PubMed ID: 12939223 [TBL] [Abstract][Full Text] [Related]
11. Fibrous cap formation or destruction--the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation. Newby AC; Zaltsman AB Cardiovasc Res; 1999 Feb; 41(2):345-60. PubMed ID: 10341834 [TBL] [Abstract][Full Text] [Related]
12. Dominant negative c-jun gene transfer inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia in rats. Yasumoto H; Kim S; Zhan Y; Miyazaki H; Hoshiga M; Kaneda Y; Morishita R; Iwao H Gene Ther; 2001 Nov; 8(22):1682-9. PubMed ID: 11892835 [TBL] [Abstract][Full Text] [Related]
13. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Owens GK; Kumar MS; Wamhoff BR Physiol Rev; 2004 Jul; 84(3):767-801. PubMed ID: 15269336 [TBL] [Abstract][Full Text] [Related]
14. The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis. Rudijanto A Acta Med Indones; 2007; 39(2):86-93. PubMed ID: 17933075 [TBL] [Abstract][Full Text] [Related]
15. The role of phospholipase C and phosphatidylinositol 3-kinase in vascular smooth muscle cell migration and proliferation. Liu B; Itoh H; Louie O; Kubota K; Kent KC J Surg Res; 2004 Aug; 120(2):256-65. PubMed ID: 15234221 [TBL] [Abstract][Full Text] [Related]
16. TGF-beta1 generates a specific multicomponent extracellular matrix in human coronary SMC. Schmidt A; Lorkowski S; Seidler D; Breithardt G; Buddecke E Eur J Clin Invest; 2006 Jul; 36(7):473-82. PubMed ID: 16796604 [TBL] [Abstract][Full Text] [Related]
18. A quantitative in vitro model of smooth muscle cell migration through the arterial wall using the human amniotic membrane. Kallenbach K; Fernandez HA; Seghezzi G; Baumann FG; Patel S; Grossi EA; Galloway AC; Mignatti P Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1008-13. PubMed ID: 12676801 [TBL] [Abstract][Full Text] [Related]